Is the use of Ro 10-9359 (Tigason) in children justified?
- PMID: 6158237
Is the use of Ro 10-9359 (Tigason) in children justified?
Abstract
In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials